ConductScience.org, home

Comparison · NCT04134845-377e9ead

Dantrolene/Ryanodex vs Placebo: Number of Participants With Inducible Sustained Ventricular Tachycardia/ Ventricular Fibrillation (VT/VF) Utilizing Standardized Stimulation Protocol.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Dantrolene/Ryanodex vs Placebo: Number of Participants With Inducible Sustained Ventricular Tachycardia/ Ventricular Fibrillation (VT/VF) Utilizing Standardized Stimulation Protocol. Trial comparisons, record NCT04134845-377e9ead. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04134845-377e9ead

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1380.0550.306wilson
Risk in group 20.4090.2330.613wilson
Risk difference, group 1 minus group 2-0.271-0.491-0.0277newcombe hybrid score
Risk ratio, group 1 over group 20.3370.1190.953log
Odds ratio, group 1 over group 20.2310.05960.896log
Number needed to treat, for one fewer participant with the outcome on Dantrolene/Ryanodex than on Placebo3.692.0436.1from the risk difference interval

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Dantrolene/RyanodexDantrolene/Ryanodex; intravenous administration of dantrolene; 1 mg/ kg IV over 3 minute, one time dose~Dantrolene/Ryanodex: muscle relaxant429OG000
Group 2Placebocontrolled placebo of saline administered Intravenous; 1 mg/kg IV over 3 minutes, one time dose~Placebo: Controlled placebo of saline administered Intravenous; 1 mg/kg IV over 3 minutes, one time dose922OG001

Outcome

Type
PRIMARY
Title
Number of Participants With Inducible Sustained Ventricular Tachycardia/ Ventricular Fibrillation (VT/VF) Utilizing Standardized Stimulation Protocol.
Description
Post drug ventricular stimulation with Right Ventricle (RV) ventricular catheter in the Right Ventricle( RV) apex with increasing extra stimuli with planned decrement stimuli by 10 milliseconds (ms) to effective refractory period (ERP). Outcome is measured as Ventricular inducibility yes/no.
Time frame
10 minutes post drug infusion
Population

Source ClinicalTrials.gov

Trial

Title
A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.
NCT number
NCT04134845
Phases
PHASE2, PHASE3
Conditions
Ventricular Tachycardia
Interventions
Dantrolene/Ryanodex, Placebo
Lead sponsor
Vanderbilt University Medical Center
Results first posted
2025-08-15

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04134845-377e9ead